Ally Bridge Group (Ny) LLC Atai Life Sciences N.V. Transaction History
Ally Bridge Group (Ny) LLC
- $97 Million
- Q3 2025
A detailed history of Ally Bridge Group (Ny) LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Ally Bridge Group (Ny) LLC holds 2,287,005 shares of ATAI stock, worth $9.15 Million. This represents 12.47% of its overall portfolio holdings.
Number of Shares
2,287,005Holding current value
$9.15 Million% of portfolio
12.47%Shares
1 transactions
Others Institutions Holding ATAI
# of Institutions
141Shares Held
38.9MCall Options Held
1.74MPut Options Held
525K-
Ubs Group Ag7.68MShares$30.7 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.43MShares$21.7 Million0.05% of portfolio
-
Morgan Stanley New York, NY4.82MShares$19.3 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.58MShares$10.3 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.02MShares$8.08 Million0.07% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $664M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...